Patients with rheumatic diseases like rheumatoid arthritis, systemic lupus erythematosus [22], and systemic sclerosis, which are characterized by a chronic inflammatory vessel activation, show reduced levels of GBP-1 in their peripheral blood [44]. This evidence concerns the gene GBP1 and systemic sclerosis.